Skip to Main Content

Paper Details

Temozolomide-induced guanine mutations create exploitable vulnerabilities of guanine-rich DNA and RNA regions in drug-resistant gliomas.
Sci Adv
6
2022
Author NameAffiliation
Bo HuLou and Jean Malnati Brain Tumor Institute, and Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine
Mihaela PerteaJohns Hopkins University
Shi-Yuan ChengLou and Jean Malnati Brain Tumor Institute, and Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine
  • 1 - 3

Datasets

Release 1.2